In addition to understanding the molecular aberrations behind gastrointestinal tumorigenesis, our ultimate goal is to identify novel diagnostic biomarkers and therapy targets. Besides gene and protein ...
Cancer biologist Scott Lowe uses genetically engineered mouse models to study how the genetic alterations in cancer cells contribute to tumorigenesis, alter treatment response, and create molecular ...